News
Ex-Jazz, Sunesis exec Swisher takes over at NodThera
Anglo-US biotech NodThera has named former Jazz Pharma executive Dan …
19724 items found
News
Digital mental health start-up Spectrum.Life raises €17m
Spectrum.Life has followed its recent rebrand with a €17 million …
News
Asahi Kasei makes $1.1bn bid to buy Calliditas
Asahi Kasei has offered to buy Sweden’s Calliditas Therapeutics for …
News
Nippon Shinyaku’s DMD drug fails confirmatory trial
The future of Nippon Shinyaku’s Duchenne muscular dystrophy (DMD) …
News
FDA sets date for Sarclisa in first-line multiple myeloma
Sanofi should hear from the FDA in September about its application …
News
AZ’s Dato-DXd misses survival endpoint in lung cancer trial
The overall survival (OS) data has come in from the TROPION-Lung01 …
News
Lilly ups spend on diabetes, obesity drug production to $9bn
Eli Lilly is determined not to be left behind when it comes to …
News
NICE, NHS England unveil new pathway for medtech
Feedback is being sought on a proposed pathway that aims to …
R&D
This week in clinical trials: 20th to 24th May
In this instalment of our renewed clinical trials round-ups, we look …
Market Access
The biosimilars dance: How drugmakers game the US patent system
When the primary patent on a blockbuster drug expires, affordable …
News
ASCO: AffyImmune claims a first with CAR-T for solid tumours
AffyImmune Therapeutics has recorded what it says is the first …
Sales & Marketing
Sponsored
Patients
Gilead's HIV success and controversy: Expanding access amid ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
